Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Increases By 722.8%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the recipient of a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 7,265 shares, an increase of 722.8% from the February 12th total of 883 shares. Based on an average daily volume of 211,031 shares, the short-interest ratio is currently 0.0 days. Based on an average daily volume of 211,031 shares, the short-interest ratio is currently 0.0 days.

Cardio Diagnostics Trading Down 7.4%

CDIOW stock traded down $0.00 during trading on Tuesday, hitting $0.03. The company had a trading volume of 17,484 shares, compared to its average volume of 79,595. The company has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.02. Cardio Diagnostics has a 52-week low of $0.01 and a 52-week high of $0.07.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.